145 related articles for article (PubMed ID: 23696930)
21. High expression of CRAM correlates with poor prognosis in patients with cervical carcinoma.
Hou T; Liang D; Yang D; He J; Huang Y; Zhang Y
Int J Clin Exp Pathol; 2014; 7(3):1060-8. PubMed ID: 24695578
[TBL] [Abstract][Full Text] [Related]
22. Prognostic relevance of Src activation in stage II-III colon cancer.
Martínez-Pérez J; Lopez-Calderero I; Saez C; Benavent M; Limon ML; Gonzalez-Exposito R; Soldevilla B; Riesco-Martínez MC; Salamanca J; Carnero A; Garcia-Carbonero R
Hum Pathol; 2017 Sep; 67():119-125. PubMed ID: 28601656
[TBL] [Abstract][Full Text] [Related]
23. Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer.
Luo M; Shen D; Wang W; Xian J
Int J Clin Exp Pathol; 2015; 8(5):5542-8. PubMed ID: 26191262
[TBL] [Abstract][Full Text] [Related]
24. Elevated CTHRC1 expression is an indicator for poor prognosis and lymph node metastasis in cervical squamous cell carcinoma.
Li N; Chen L; Liu C; Jiang Y; Rong J
Hum Pathol; 2019 Mar; 85():235-241. PubMed ID: 30381261
[TBL] [Abstract][Full Text] [Related]
25. Prognostic relevance of TGF-beta1 and PAI-1 in cervical cancer.
Hazelbag S; Kenter GG; Gorter A; Fleuren GJ
Int J Cancer; 2004 Dec; 112(6):1020-8. PubMed ID: 15386352
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of post-radiation serum squamous cell carcinoma antigen and primary tumor regression for cervical squamous cell carcinoma.
Wan Q; Yan W; Liu Y; Lin Y; Lu Z
Cancer Biomark; 2020; 29(3):327-335. PubMed ID: 32716344
[TBL] [Abstract][Full Text] [Related]
27. 5-Hydroxymethylcytosine expression is associated with poor survival in cervical squamous cell carcinoma.
Zhang LY; Han CS; Li PL; Zhang XC
Jpn J Clin Oncol; 2016 May; 46(5):427-34. PubMed ID: 26851753
[TBL] [Abstract][Full Text] [Related]
28. [Carcinomas of the uterine cervix in young women: study of the French cooperative group].
Barillot I; Horiot JC; Pigneux J; Schraub S; Rozan R; Daly N; Bolla M; Pourquier H
Bull Cancer Radiother; 1994; 81(4):432-6. PubMed ID: 7702931
[No Abstract] [Full Text] [Related]
29. FAK and Src expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival.
Theocharis S; Klijanienko J; Giaginis C; Alexandrou P; Patsouris E; Sastre-Garau X
J Cancer Res Clin Oncol; 2012 Aug; 138(8):1369-77. PubMed ID: 22488171
[TBL] [Abstract][Full Text] [Related]
30. High TMPRSS4 expression is a predictor of poor prognosis in cervical squamous cell carcinoma.
Cheng D; Liang B; Li Y
Cancer Epidemiol; 2013 Dec; 37(6):993-7. PubMed ID: 24012692
[TBL] [Abstract][Full Text] [Related]
31. Focal adhesion kinase as a marker of malignant phenotype in breast and cervical carcinomas.
Oktay MH; Oktay K; Hamele-Bena D; Buyuk A; Koss LG
Hum Pathol; 2003 Mar; 34(3):240-5. PubMed ID: 12673558
[TBL] [Abstract][Full Text] [Related]
32. Preoperative SCC-Ag as a predictive marker for the use of adjuvant chemotherapy in cervical squamous cell carcinoma with intermediate-risk factors.
Guo HT; Bi XH; Lei T; Lv X; Yao G; Chen Y; Liu C
BMC Cancer; 2020 May; 20(1):441. PubMed ID: 32429859
[TBL] [Abstract][Full Text] [Related]
33. Wnt5A expression is associated with the tumor metastasis and clinical survival in cervical cancer.
Lin L; Liu Y; Zhao W; Sun B; Chen Q
Int J Clin Exp Pathol; 2014; 7(9):6072-8. PubMed ID: 25337253
[TBL] [Abstract][Full Text] [Related]
34. Mixed lineage kinase domain-like protein is a prognostic biomarker for cervical squamous cell cancer.
Ruan J; Mei L; Zhu Q; Shi G; Wang H
Int J Clin Exp Pathol; 2015; 8(11):15035-8. PubMed ID: 26823841
[TBL] [Abstract][Full Text] [Related]
35. PAK4 confers the malignance of cervical cancers and contributes to the cisplatin-resistance in cervical cancer cells via PI3K/AKT pathway.
Shu XR; Wu J; Sun H; Chi LQ; Wang JH
Diagn Pathol; 2015 Sep; 10():177. PubMed ID: 26411419
[TBL] [Abstract][Full Text] [Related]
36. Clinical value of thymidine kinase in patients with cervical carcinoma.
Fujiwaki R; Hata K; Moriyama M; Iwanari O; Katabuchi H; Okamura H; Miyazaki K
Oncology; 2001; 61(1):47-54. PubMed ID: 11474248
[TBL] [Abstract][Full Text] [Related]
37. No relationship is indicated between FHIT expression and clinicopathologic prognostic parameters in early stage cervical carcinoma.
Baykal C; Ayhan A; Al A; Yüce K; Ayhan A
Int J Gynecol Cancer; 2003; 13(2):192-6. PubMed ID: 12657123
[TBL] [Abstract][Full Text] [Related]
38. Factors Associated with Recurrence and Regional Adenopathy for Head and Neck Cutaneous Squamous Cell Carcinoma.
Harris BN; Bayoumi A; Rao S; Moore MG; Farwell DG; Bewley AF
Otolaryngol Head Neck Surg; 2017 May; 156(5):863-869. PubMed ID: 28322123
[TBL] [Abstract][Full Text] [Related]
39. LRIG2 in contrast to LRIG1 predicts poor survival in early-stage squamous cell carcinoma of the uterine cervix.
Hedman H; Lindström AK; Tot T; Stendahl U; Henriksson R; Hellberg D
Acta Oncol; 2010 Aug; 49(6):812-5. PubMed ID: 20553099
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathological and prognostic significance of Bmi-1 expression in human cervical cancer.
Min L; Dong-Xiang S; Xiao-Tong G; Ting G; Xiao-Dong C
Acta Obstet Gynecol Scand; 2011 Jul; 90(7):737-45. PubMed ID: 21309753
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]